NO305365B1 - Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter - Google Patents

Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter

Info

Publication number: NO305365B1
Authority: NO; Norway
Prior art keywords: opt; substd; alkyl; derivatives; phenyl
Prior art date: 1994-10-04

Application number

NO953930A

Other languages

English (en)

Norwegian (no)

Other versions

NO953930D0 (no

NO953930L (no

Inventor

Ulrich Mueller

Richard Connell

Siegfried Goldmann

Rudi Gruetzmann

Martin Beuck

Hilmar Bischoff

Dirk Denzer

Anke Domdey-Bette

Stefan Wohlfeil

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-04

Filing date

1995-10-03

Publication date

1999-05-18

1995-10-03 Application filed by Bayer Ag filed Critical Bayer Ag

1995-10-03 Publication of NO953930D0 publication Critical patent/NO953930D0/no

1996-04-09 Publication of NO953930L publication Critical patent/NO953930L/no

1999-05-18 Publication of NO305365B1 publication Critical patent/NO305365B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO953930A 1994-10-04 1995-10-03 Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter NO305365B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4435477A DE4435477A1 (de)	1994-10-04	1994-10-04	Cycloalkano-indol- und -azaindol-derivate

Publications (3)

Publication Number	Publication Date
NO953930D0 NO953930D0 (no)	1995-10-03
NO953930L NO953930L (no)	1996-04-09
NO305365B1 true NO305365B1 (no)	1999-05-18

Family

ID=6529939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO953930A NO305365B1 (no)	1994-10-04	1995-10-03	Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter

Country Status (36)

Country	Link
US (6)	US5684014A (zh)
EP (1)	EP0705831B1 (zh)
JP (1)	JP3901234B2 (zh)
KR (1)	KR100355986B1 (zh)
CN (2)	CN1183111C (zh)
AT (1)	ATE255580T1 (zh)
AU (1)	AU700609B2 (zh)
CA (1)	CA2159546C (zh)
CZ (1)	CZ291348B6 (zh)
DE (2)	DE4435477A1 (zh)
DK (1)	DK0705831T3 (zh)
DZ (1)	DZ1934A1 (zh)
EE (1)	EE03527B1 (zh)
ES (1)	ES2211890T3 (zh)
FI (2)	FI113048B (zh)
HK (1)	HK1005139A1 (zh)
HN (1)	HN1995009160A (zh)
HR (1)	HRP950505B1 (zh)
HU (1)	HU225052B1 (zh)
IL (3)	IL129641A0 (zh)
MA (1)	MA23683A1 (zh)
MY (1)	MY117282A (zh)
NO (1)	NO305365B1 (zh)
NZ (1)	NZ280130A (zh)
PH (1)	PH31400A (zh)
PL (1)	PL183154B1 (zh)
PT (1)	PT705831E (zh)
RU (1)	RU2157803C2 (zh)
SG (1)	SG63528A1 (zh)
SI (1)	SI0705831T1 (zh)
SK (1)	SK284260B6 (zh)
SV (1)	SV1995000062A (zh)
TN (1)	TNSN95098A1 (zh)
TW (1)	TW448175B (zh)
UA (1)	UA44700C2 (zh)
ZA (1)	ZA958297B (zh)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4435477A1 (de)	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19525028A1 (de) *	1995-07-10	1997-01-16	Bayer Ag	Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
DE19613549A1 (de) *	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
US6774236B1 (en)	1996-04-04	2004-08-10	Bayer Aktiengesellschaft	Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19615119A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide
DE19619950A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) *	1996-04-17	1997-10-22	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19615265A1 (de) *	1996-04-18	1997-12-04	Bayer Ag	Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
EP1073440B1 (en) *	1998-05-01	2004-10-20	Eli Lilly And Company	sPLA 2 INHIBITOR ESTERS
DE69914563T2 (de) *	1998-10-30	2004-12-16	Eli Lilly And Co., Indianapolis	Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
AU4616200A (en) *	1999-05-25	2000-12-12	Yamanouchi Pharmaceutical Co., Ltd.	Hydrazide derivatives
DE19929065A1 (de) *	1999-06-25	2000-12-28	Bayer Ag	Kombination von MTP-Inhibitoren und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
DE19934610A1 (de) *	1999-07-23	2001-01-25	Bayer Ag	Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
MXPA02007981A (es) *	2000-03-15	2004-04-05	Aventis Pharma Gmbh	Beta-carbolinas sustituidas con actividad que inhibe la ikb-cinasa.
EP1134221A1 (en) *	2000-03-15	2001-09-19	Aventis Pharma Deutschland GmbH	Substituted beta-carbolines as lkB kinase inhibitors
AU2001244635A1 (en) *	2000-03-30	2001-10-15	Yamanouchi Pharmaceutical Co..Ltd.	Hydrazide derivatives
DE10030375A1 (de) *	2000-06-21	2002-01-03	Bayer Ag	Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
CA2671776C (en) *	2001-01-31	2012-12-18	H. Lundbeck A/S	Gal3 receptor antagonists for the treatment of depression
CN1630629B (zh) *	2002-02-28	2010-05-05	日本烟草产业株式会社	酯化合物及其医药用途
US20050239780A1 (en) *	2002-05-31	2005-10-27	Akira Suga	Tetrahydropyran derivative
WO2004063156A1 (en) *	2003-01-08	2004-07-29	Biovitrum Ab	Novel indole derivates as fabp-4 inhibitors
WO2005051382A1 (ja) *	2003-11-28	2005-06-09	Astellas Pharma Inc.	脂質低下作用増強剤
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
ES2399721T5 (es)	2004-03-05	2016-05-25	Univ Pennsylvania	Métodos para tratar trastornos o enfermedades asociados a la hiperlipidemia e hipercolesterolemia minimizando los efectos adversos
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
CA2562015A1 (en) *	2004-04-09	2005-10-20	Janssen Pharmaceutica Nv	Intermittent dosing regimens of apob secretion/mtp inhibitors for overweith and obese subjects
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US20060030623A1 (en) *	2004-07-16	2006-02-09	Noboru Furukawa	Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
FR2873694B1 (fr) *	2004-07-27	2006-12-08	Merck Sante Soc Par Actions Si	Nouveaux aza-indoles inhibiteurs de la mtp et apob
US8101774B2 (en) *	2004-10-18	2012-01-24	Japan Tobacco Inc.	Ester derivatives and medicinal use thereof
EP1806149A4 (en) *	2004-10-25	2012-12-05	Japan Tobacco Inc	SOLID MEDICINAL PREPARATION IMPROVED IN TERMS OF SOLUBILITY AND STABILITY AND METHOD FOR PRODUCING SAME
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
WO2006129193A2 (en) *	2005-05-27	2006-12-07	Pfizer Products Inc.	Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
JP2009503050A (ja) *	2005-08-04	2009-01-29	ファイザー・リミテッド	ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物
AU2006304531A1 (en) *	2005-10-18	2007-04-26	Aegerion Pharmaceuticals	Methods for treating disorders associated with hyperlipidemia in a mammal
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
DK1989196T3 (da) *	2006-02-23	2013-04-15	Pfizer Ltd	Piperidinoylpyrrolidiner som melanocortin-type 4-receptoragonister
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
WO2007135461A2 (en) *	2006-05-18	2007-11-29	Bayer Healthcare Ag	Pharmaceutical compositions comprising implitapide and methods of using same
WO2008059335A1 (en)	2006-11-13	2008-05-22	Pfizer Products Inc.	Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
WO2008070496A2 (en)	2006-12-01	2008-06-12	Bristol-Myers Squibb Company	N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
JP2010513534A (ja) *	2006-12-21	2010-04-30	エージェリオンファーマシューティカルズ，インコーポレイテッド	Ｍｔｐインヒビターおよびコレステロール吸収インヒビターを含む組み合わせを用いて肥満症を処置する方法
RU2338745C1 (ru) *	2007-03-21	2008-11-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2008124384A2 (en) *	2007-04-03	2008-10-16	Aegerion Pharmaceuticals, Inc.	Combinations of mtp inhibitors with cholesterol absorption inhibitors or interferon for treating hepatitis c
JP5530438B2 (ja) *	2008-08-06	2014-06-25	ファイザー・リミテッド	Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物
PT2968284T (pt)	2013-03-14	2021-06-28	Osteoqc Inc	Derivados alquilamina de harmina para promoção de crescimento ósseo
JP6782227B2 (ja) *	2014-09-05	2020-11-11	ザ・ジョンズ・ホプキンス・ユニバーシティー	ＣａＭＫＩＩ阻害剤及びその使用
CN108218862B (zh) *	2018-02-07	2020-06-23	贵州医科大学	α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用
CN110467560A (zh) *	2018-05-09	2019-11-19	深圳微芯生物科技股份有限公司	一种苯基氨基丙酸钠衍生物、其制备方法和应用
CN113166058A (zh)	2018-08-14	2021-07-23	奥斯特克有限公司	氟β-咔啉化合物
KR20210075071A (ko)	2018-08-14	2021-06-22	오스테오큐씨 인코포레이티드	피롤로-디피리딘 화합물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH501623A (de) *	1967-12-18	1971-01-15	Ruetgerswerke Ag	Verfahren zur Herstellung von 2-Chlorpyridin und seinen Derivaten
US4808608A (en) *	1986-01-23	1989-02-28	Merck & Co., Inc.	Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
ES2038653T3 (es) *	1986-01-23	1993-08-01	Merck Frosst Canada Inc.	Acidos 1-alcanoicos tetrahidrocarbazol.
US4940719A (en) *	1986-03-27	1990-07-10	Merck Frosst Canada, Inc.	Tetrahydrocarbazole esters, pharmaceutical compositions and use
US4775680A (en) *	1987-07-21	1988-10-04	Merck & Co., Inc.	Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
CA1326030C (en) *	1987-07-21	1994-01-11	John W. Gillard	Cyclohept[b]indolealkanoic acids
GB9101375D0 (en) *	1991-01-22	1991-03-06	Erba Carlo Spa	N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
DE4112533A1 (de) *	1991-04-17	1992-10-22	Bayer Ag	Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de)	1991-04-26	1992-10-29	Bayer Ag	Heterocyclisch substituierte phenylessigsaeurederivate
DE4308788A1 (de) *	1993-03-18	1994-09-22	Bayer Ag	Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19613549A1 (de)	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide

1994
- 1994-10-04 DE DE4435477A patent/DE4435477A1/de not_active Withdrawn
1995
- 1995-02-07 HN HN1995009160A patent/HN1995009160A/es unknown
- 1995-09-21 ES ES95114877T patent/ES2211890T3/es not_active Expired - Lifetime
- 1995-09-21 EP EP95114877A patent/EP0705831B1/de not_active Expired - Lifetime
- 1995-09-21 DE DE59510839T patent/DE59510839D1/de not_active Expired - Lifetime
- 1995-09-21 PT PT95114877T patent/PT705831E/pt unknown
- 1995-09-21 DK DK95114877T patent/DK0705831T3/da active
- 1995-09-21 SI SI9530693T patent/SI0705831T1/xx unknown
- 1995-09-21 AT AT95114877T patent/ATE255580T1/de not_active IP Right Cessation
- 1995-09-27 HR HR950505A patent/HRP950505B1/xx not_active IP Right Cessation
- 1995-09-27 AU AU32920/95A patent/AU700609B2/en not_active Ceased
- 1995-09-28 US US08/535,698 patent/US5684014A/en not_active Expired - Lifetime
- 1995-09-29 CA CA2159546A patent/CA2159546C/en not_active Expired - Fee Related
- 1995-09-29 NZ NZ280130A patent/NZ280130A/en not_active IP Right Cessation
- 1995-10-02 DZ DZ950116A patent/DZ1934A1/fr active
- 1995-10-02 IL IL12964199A patent/IL129641A0/xx unknown
- 1995-10-02 TW TW084110247A patent/TW448175B/zh active
- 1995-10-02 FI FI954681A patent/FI113048B/fi active
- 1995-10-02 KR KR1019950033651A patent/KR100355986B1/ko not_active IP Right Cessation
- 1995-10-02 MA MA24027A patent/MA23683A1/fr unknown
- 1995-10-02 IL IL11549395A patent/IL115493A/xx not_active IP Right Cessation
- 1995-10-02 IL IL12964195A patent/IL129641A/xx not_active IP Right Cessation
- 1995-10-02 TN TNTNSN95098A patent/TNSN95098A1/fr unknown
- 1995-10-03 EE EE9500071A patent/EE03527B1/xx not_active IP Right Cessation
- 1995-10-03 RU RU95117070/04A patent/RU2157803C2/ru not_active IP Right Cessation
- 1995-10-03 NO NO953930A patent/NO305365B1/no not_active IP Right Cessation
- 1995-10-03 SG SG1995001478A patent/SG63528A1/en unknown
- 1995-10-03 HU HU9502891A patent/HU225052B1/hu not_active IP Right Cessation
- 1995-10-03 SK SK1239-95A patent/SK284260B6/sk not_active IP Right Cessation
- 1995-10-03 UA UA95104372A patent/UA44700C2/uk unknown
- 1995-10-03 CZ CZ19952567A patent/CZ291348B6/cs not_active IP Right Cessation
- 1995-10-03 PL PL95310756A patent/PL183154B1/pl not_active IP Right Cessation
- 1995-10-03 JP JP27966495A patent/JP3901234B2/ja not_active Expired - Fee Related
- 1995-10-03 ZA ZA958297A patent/ZA958297B/xx unknown
- 1995-10-03 PH PH51415A patent/PH31400A/en unknown
- 1995-10-04 CN CNB981260853A patent/CN1183111C/zh not_active Expired - Fee Related
- 1995-10-04 CN CN95117117A patent/CN1050605C/zh not_active Expired - Fee Related
- 1995-10-04 MY MYPI95002964A patent/MY117282A/en unknown
- 1995-10-04 SV SV1995000062A patent/SV1995000062A/es active IP Right Grant
1997
- 1997-07-03 US US08/887,781 patent/US6245775B1/en not_active Expired - Lifetime
1998
- 1998-05-19 HK HK98104346A patent/HK1005139A1/xx not_active IP Right Cessation
1999
- 1999-05-17 US US09/313,035 patent/US6265431B1/en not_active Expired - Lifetime
2000
- 2000-12-08 FI FI20002693A patent/FI108791B/fi active
- 2000-12-11 US US09/734,955 patent/US20020147209A1/en not_active Abandoned
2001
- 2001-03-21 US US09/814,263 patent/US6479503B2/en not_active Expired - Lifetime
2002
- 2002-07-18 US US10/198,315 patent/US6858622B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SK284260B6 (sk)	2004-12-01
TW448175B (en)	2001-08-01
FI954681A0 (fi)	1995-10-02
SK123995A3 (en)	1996-06-05
SG63528A1 (en)	1999-03-30
HRP950505A2 (en)	1997-08-31
CN1183111C (zh)	2005-01-05
ES2211890T3 (es)	2004-07-16
KR100355986B1 (ko)	2003-01-06
CN1224715A (zh)	1999-08-04
FI20002693A (fi)	2000-12-08
CN1050605C (zh)	2000-03-22
EP0705831A3 (de)	1997-01-22
JPH08225526A (ja)	1996-09-03
DZ1934A1 (fr)	2002-02-17
HUT73240A (en)	1996-07-29
EE9500071A (et)	1996-04-15
RU2157803C2 (ru)	2000-10-20
IL129641A (en)	2000-08-31
KR960014126A (ko)	1996-05-22
JP3901234B2 (ja)	2007-04-04
US20020147209A1 (en)	2002-10-10
EE03527B1 (et)	2001-10-15
ATE255580T1 (de)	2003-12-15
CA2159546C (en)	2010-12-14
US20020055635A1 (en)	2002-05-09
DE4435477A1 (de)	1996-04-11
HN1995009160A (es)	2000-04-24
CZ256795A3 (en)	1996-04-17
PL183154B1 (pl)	2002-05-31
FI108791B (fi)	2002-03-28
ZA958297B (en)	1996-05-06
FI113048B (fi)	2004-02-27
UA44700C2 (uk)	2002-03-15
US20030149073A1 (en)	2003-08-07
IL129641A0 (en)	2000-02-29
IL115493A0 (en)	1996-01-19
EP0705831B1 (de)	2003-12-03
PL310756A1 (en)	1996-04-15
HK1005139A1 (en)	1998-12-24
PT705831E (pt)	2004-04-30
NZ280130A (en)	1996-05-28
US6479503B2 (en)	2002-11-12
PH31400A (en)	1998-10-29
US6858622B2 (en)	2005-02-22
FI954681A (fi)	1996-04-05
CA2159546A1 (en)	1996-04-05
TNSN95098A1 (fr)	1996-02-06
AU700609B2 (en)	1999-01-07
DE59510839D1 (de)	2004-01-15
US6245775B1 (en)	2001-06-12
MY117282A (en)	2004-06-30
DK0705831T3 (da)	2004-04-05
HU9502891D0 (en)	1995-11-28
SI0705831T1 (en)	2004-02-29
NO953930D0 (no)	1995-10-03
AU3292095A (en)	1996-04-18
EP0705831A2 (de)	1996-04-10
CZ291348B6 (cs)	2003-02-12
NO953930L (no)	1996-04-09
HU225052B1 (en)	2006-05-29
CN1130631A (zh)	1996-09-11
SV1995000062A (es)	1996-07-10
US5684014A (en)	1997-11-04
US6265431B1 (en)	2001-07-24
HRP950505B1 (en)	2002-04-30
IL115493A (en)	1999-10-28
MA23683A1 (fr)	1996-07-01

Publication	Publication Date	Title
NO305365B1 (no)	1999-05-18	Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter
ATE204269T1 (de)	2001-09-15	Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
CA2195027A1 (en)	1993-05-09	HIV Protease Inhibitors Useful for the Treatment of AIDS
FR2619111B1 (fr)	1991-01-11	Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
PL310460A1 (en)	1996-03-18	Novel derivatives of imidazopyridine, method of obtaining them and drugs containing such derivatives
ES2195382T3 (es)	2003-12-01	Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
ATE197794T1 (de)	2000-12-15	Benzyloxy-substituierte phenylglycinolamide als arzneimittel
IL119054A (en)	2000-10-31	Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2011-05-30	MM1K	Lapsed by not paying the annual fees